FLEX PHARMA INC's ticker is FLKS and the CUSIP is 33938A105. A total of 27 filers reported holding FLEX PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $97,000 | +361.9% | 175,716 | +208.6% | 0.00% | – |
| Q1 2019 | $21,000 | -41.7% | 56,938 | -50.0% | 0.00% | – |
| Q4 2018 | $36,000 | +38.5% | 113,876 | +100.0% | 0.00% | – |
| Q3 2018 | $26,000 | -50.9% | 56,938 | 0.0% | 0.00% | – |
| Q2 2018 | $53,000 | -81.3% | 56,938 | 0.0% | 0.00% | – |
| Q1 2018 | $284,000 | +43.4% | 56,938 | 0.0% | 0.00% | – |
| Q4 2017 | $198,000 | -2.5% | 56,938 | -4.7% | 0.00% | – |
| Q3 2017 | $203,000 | -11.7% | 59,760 | 0.0% | 0.00% | – |
| Q2 2017 | $230,000 | -35.4% | 59,760 | -26.2% | 0.00% | – |
| Q1 2017 | $356,000 | -11.7% | 80,986 | +5.9% | 0.00% | – |
| Q4 2016 | $403,000 | -54.0% | 76,442 | +2.7% | 0.00% | – |
| Q3 2016 | $876,000 | +18.5% | 74,430 | +2.8% | 0.00% | – |
| Q2 2016 | $739,000 | +4.1% | 72,428 | +11.8% | 0.00% | – |
| Q1 2016 | $710,000 | -12.0% | 64,788 | -0.1% | 0.00% | – |
| Q4 2015 | $807,000 | +4.7% | 64,842 | +1.0% | 0.00% | – |
| Q3 2015 | $771,000 | -27.3% | 64,228 | +4.1% | 0.00% | -100.0% |
| Q2 2015 | $1,061,000 | – | 61,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 933,691 | $11,214,000 | 5.10% |
| ACUTA CAPITAL PARTNERS, LLC | 88,716 | $1,065,000 | 0.62% |
| PURA VIDA INVESTMENTS, LLC | 72,000 | $865,000 | 0.49% |
| Lombard Odier Asset Management (USA) Corp | 109,084 | $1,310,000 | 0.11% |
| Tekla Capital Management LLC | 232,600 | $2,794,000 | 0.10% |
| Abingworth LLP | 10,000 | $120,000 | 0.07% |
| Nicholas Investment Partners, LP | 56,601 | $680,000 | 0.05% |
| C WorldWide Group Holding A/S | 71,700 | $756,000 | 0.01% |
| JENNISON ASSOCIATES LLC | 656,651 | $7,886,000 | 0.01% |
| VANGUARD GROUP INC | 4,654,700 | $146,091,000 | 0.01% |